Surgical vs Non-Surgical Treatment for Hip Fracture
Trial Summary
What is the purpose of this trial?
Lateral compression-1 (LC1) pelvic ring fragility fractures cause significant pain and morbidity. These fragility injuries are associated with prolonged immobility and long hospital stays. Currently there is no consensus on operative stabilization of LC1 pelvic fractures, nor are there evidence-based guidelines to aid in management of these injury types. Furthermore, there is variability in operative indications, improvement in pain and mobilization. The purpose of this study is to compare percutaneous screw fixation to non-operative management in symptomatic LC1 fragility fractures in elderly patients.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Percutaneous transiliac-transsacral screw fixation for hip fractures?
Research shows that percutaneous transiliac-transsacral screw fixation can improve pain, walking ability, and the likelihood of returning home in patients with sacral fragility fractures. It is also effective for reducing pain in sacral insufficiency fractures that do not respond to non-surgical treatments.12345
Is percutaneous transiliac-transsacral screw fixation generally safe for humans?
How does percutaneous transiliac-transsacral screw fixation differ from other treatments for hip fractures?
Percutaneous transiliac-transsacral screw fixation is a minimally invasive surgical technique that stabilizes fractures by inserting screws through the ilium (hip bone) and sacrum (base of the spine), which can improve pain and mobility with fewer complications compared to more invasive surgeries.12345
Research Team
Mai P. Nguyen, MD
Principal Investigator
University of Minnesota and HealthPartners
Eligibility Criteria
This trial is for people aged 60 or older with a specific type of pelvic fracture (LC1) caused by low energy events like falls. They must have significant pain or difficulty moving even with help, and the injury should be recent, within four weeks. It's not for those with certain implants, unstable fractures, neurological issues, dementia, cancer-related fractures, non-walkers before the injury, other studies' participants or if they can't follow up.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either percutaneous screw fixation or non-operative treatment with physical therapy and pain management
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessments like TUG and pain scale
Long-term follow-up
Participants are monitored for long-term outcomes such as complications and mortality
Treatment Details
Interventions
- Percutaneous transiliac - transsacral screw fixation
Percutaneous transiliac - transsacral screw fixation is already approved in United States, European Union for the following indications:
- Geriatric lateral compression-1 (LC1) pelvic ring fragility fractures
- Unstable pelvic fractures
- Posterior pelvic ring injuries
- Pelvic ring injuries
- Geriatric fragility fractures
- Unstable pelvic fractures
Find a Clinic Near You
Who Is Running the Clinical Trial?
HealthPartners Institute
Lead Sponsor
Orthopaedic Trauma Association
Collaborator
Allina Health System
Collaborator